Q4 2021 Holdings
Filed 2022-02-14 | 71 holdings | $31.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.3M | 850,935 | 23.0% |
| Cerus Corp(CERS) | COM | 157085101 | $7.1M | 1,042,722 | 22.4% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.2M | 286,226 | 13.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.2M | 111,860 | 10.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.7M | 58,190 | 8.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $2.3M | 100,000 | 7.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.7M | 45,132 | 5.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.7M | 100,000 | 5.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.4M | 5,744 | 4.3% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $22.4K | 200,000 | 0.1% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $11.2K | 1,514,411 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $11.1K | 80,348 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $10.2K | 195,000 | 0.0% |
| Merus N V | COM | N5749R100 | $10.2K | 320,174 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $9.1K | 221,362 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.9K | 60,757 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $8.9K | 1,100,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $7.1K | 128,901 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $6.6K | 61,700 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $6.4K | 138,006 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $6.2K | 739,604 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $5.4K | 556,890 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.3K | 391,155 | 0.0% |
| Lucira Health Inc | COM | 54948U105 | $4.4K | 515,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $4.2K | 192,045 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $3.8K | 350,213 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $3.7K | 1,483,829 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $3.3K | 1,013,664 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.3K | 46,670 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $3.2K | 67,440 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.1K | 14,551 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1K | 100,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $2.9K | 71,009 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.7K | 100,621 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $2.7K | 320,602 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $2.5K | 1,199,814 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.4K | 123,806 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $2.4K | 427,847 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.2K | 181,886 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.2K | 100,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $2.1K | 344,236 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $2.1K | 245,829 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $1.8K | 458,466 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $1.7K | 1,498,192 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $1.7K | 10,848 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $1.6K | 234,932 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $1.6K | 160,526 | 0.0% |
| Benitec Biopharma Inc(BNTC1EUR) | COM | 08205P100 | $1.5K | 587,499 | 0.0% |
| Eloxx Pharmaceuticals Inc | COM | 29014R103 | $1.4K | 1,930,092 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $1.3K | 131,823 | 0.0% |